Terminated PHASE2 INTERVENTIONAL 2-arm NCT00672633

Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides

A Double Blind Randomized Controlled Trial of Lovaza in Adolescents With Mild to Moderately Elevated Triglycerides.

Sponsor: Boston Children's Hospital

Updated 7 times since 2017 Last updated: May 24, 2013 Started: Apr 30, 2008 Primary completion: Dec 31, 2011 Completion: Mar 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Very slow recruitment.

Other terminated trials from Boston Children's Hospital

See all terminations from Boston Children's Hospital

Other Hypertriglyceridemia trials with similar outcome

Browse all Hypertriglyceridemia trials

This PHASE2 trial investigates Hypertriglyceridemia and is currently terminated or withdrawn. Boston Children's Hospital leads this study, which shows 7 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Dec 2021 — Jul 2024 [monthly]

Terminated PHASE2
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE2
Sep 2020 — Jan 2021 [monthly]

Terminated PHASE2

▶ Show 2 earlier versions

Jun 2018 — Sep 2020 [monthly]

Terminated PHASE2
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE2

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Boston Children's Hospital
GlaxoSmithKline

Data source: Boston Children's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States